Canary Wharf
- Statistics and Probability top 5%
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions 3
-
- Pharmaceutical studies and practices 5
-
- Pharmaceutical Economics and Policy 4
-
- Pharmaceutical industry and healthcare 2
-
- Biomedical Ethics and Regulation 2
-
- Antibiotic Resistance in Bacteria 2
-
- Phytochemistry and Biological Activities 2
- Botany, Ecology, and Taxonomy Studies 2
Canary Wharf
33 papers receiving 476 citations
Peers
Comparison fields: 5 of 123
- Statistics and Probability 63
- Toxicology 22
- Cancer Research 79
- Pharmaceutical Science 25
- Small Animals 23
Countries citing papers authored by Canary Wharf
This map shows the geographic impact of Canary Wharf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Canary Wharf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canary Wharf more than expected).
Fields of papers citing papers by Canary Wharf
This network shows the impact of papers produced by Canary Wharf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Canary Wharf. The network helps show where Canary Wharf may publish in the future.
Co-authorship network
The 8 scholars most cited alongside Canary Wharf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | EMA Procedural advice for users of the centralised procedure for generic/hybrid applications | 2015 | 3 |
| 2 | European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure | 2015 | 11 |
| 3 | EMA Procedural advice for users of the Centralised Procedure for Similar Biological Medicinal Products applications | 2015 | 9 |
| 4 | Withdrawal assessment report | 2014 | 1 |
| 5 | Overview of comments received on 'Answers to the request for scientific advice on the impact on public health and animal health of the use of antibiotics in animals' (EMA/381884/2014) | 2014 | 4 |
| 6 | CHMP extension of indication variation assessment report | 2014 | 7 |
| 7 | Answers to the requests for scientific advice on the impact on public health and animal health of the use of antibiotics in animals | 2014 | 15 |
| 8 | Assessment report on Agrimonia eupatoria L., herba | 2014 | 3 |
| 9 | Background review for cyclodextrins used as excipients | 2014 | 30 |
| 10 | Overview of comments received on Community herbal monograph on Thymus vulgaris L. and Thymus zygis L., herba and Primula veris L. and Primula elatior (L.) Hill, radix (EMA/HMPC/130042/2010) | 2013 | 6 |
| 11 | Assessment report on Sambucus nigra L., fructus | 2013 | 14 |
| 12 | ICH guideline S2 (R1) on genotoxicity testing and data interpretation for pharmaceuticals intended for human | 2013 | 128 |
| 13 | Reflection paper on risk based quality management in clinical trials | 2013 | 51 |
| 14 | Guidelines on good pharmacovigilance practices (GVP) | 2012 | 6 |
| 15 | Reflection paper on classification of advanced therapy medicinal products | 2012 | 34 |
| 16 | Paediatric addendum to CHMP guideline on clinical investigation of medicinal products in the treatment of lipid disorders | 2012 | 8 |
| 17 | Pharmacovigilance Working Party (PhVWP) | 2011 | 12 |
| 18 | Public statement on Chelidonium majus L., herba | 2011 | 1 |
| 19 | EVALUATION OF MICROPAYMENT TRANSACTION COSTS | 2004 | 19 |
| 20 | MOBILISATION OF TRAPPED GAS FROM BELOW THE GAS-WATER CONTACT | 2004 | 2 |
About Canary Wharf
Canary Wharf is a scholar working on Toxicology, Molecular Medicine and Gastroenterology, having authored 34 papers that have together received 504 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (5 papers), Pharmaceutical Economics and Policy (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Pharmaceutical industry and healthcare (2 papers), Biomedical Ethics and Regulation (2 papers), Antibiotic Resistance in Bacteria (2 papers), Phytochemistry and Biological Activities (2 papers) and Botany, Ecology, and Taxonomy Studies (2 papers). The work is most often cited by research in Statistics and Probability (63 citations), Toxicology (22 citations) and Cancer Research (79 citations). Frequent co-authors include Edythe D. London, E. S. London, Elisha London, Ioannis Papaefstathiou, Charalampos Manifavas, Erwin London, Kevin O’Malley and Elizabeth London.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.